Fully invested in Expertise

Our Team

Launch Therapeutics is backed by leading investors, Carlyle and its life sciences franchise, Abingworth.

Launch Tx was formed in 2022 with the vision of assembling an exceptional team that could redefine late-stage development. The goal? Expediting the pathway for therapies to be approved, and ultimately, delivered to the patients who need them. Meet the team of passionate professionals who are deeply committed to both the science – and the art – of delivering on that promise.